Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 16.11.2020 | EN | Official Journal of the European Union | C 390/40 |

---

Action brought on 15 September 2020 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)

(Case T-584/20)

(2020/C 390/57)

Language of the case: English

Parties

Applicant: Cara Therapeutics, Inc. (Wilmington, Delaware, United States) (represented by: J. Day, Solicitor and T. de Haan, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Gebro Holding GmbH (Fieberbrunn, Austria)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union word mark KORSUVA — Application for registration No 17 816 844

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 3 July 2020 in Case R 2450/2019-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | uphold the decision of the Opposition Division of 27 January 2018 in Opposition No B 002437922; |

|  |  |
| --- | --- |
| — | allow the contested application to proceed to registration; |

|  |  |
| --- | --- |
| — | order EUIPO and Gebro Holdings GmbH to bear their own costs and pay those of the Applicant. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)